SURUFATINIB
Clinical trials for SURUFATINIB explained in plain language.
Never miss a new study
Get alerted when new SURUFATINIB trials appear
Sign up with your email to follow new studies for SURUFATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple therapy takes on tough lung cancer
Disease control Recruiting nowThis phase II trial tests whether adding two drugs—toripalimab (an immunotherapy) and surufatinib (a targeted therapy)—to standard chemoradiation can help people with limited-stage small cell lung cancer live longer without the disease getting worse. About 47 adults aged 18–75 wi…
Matched conditions: SURUFATINIB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Experimental cocktail aims to shrink untreatable esophageal tumors
Disease control Recruiting nowThis phase II trial tests whether adding the drug surufatinib to standard chemo-immunotherapy and radiation can help people with advanced esophageal cancer that cannot be removed by surgery. The study will enroll 69 participants in China and track how long they live without the c…
Matched conditions: SURUFATINIB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC